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DNA profiles do not provide as much evidentiary value when either all known samples can be 
excluded or when there is no known suspect. DNA phenotyping is a technique used for 
investigative purposes to predict externally visible characteristics (EVCs) based on specific 
markers found in the genome. Most phenotyping panels are currently restricted to markers stable 
over a lifetime within an individual and are not able to predict environmental or metabolic 
impacts on EVCs. It is known that miRNA expression levels change due to environmental and 
metabolic factors, such as BMI, and research has proven associations between circulating plasma 
miRNAs and BMI. In this project, 25 dried whole blood swabs were prepared from individuals 
with varying BMI values. To accommodate the typical forensic casework protocol, a DNA 
extraction method (QIAamp DNA Investigator Kit) was utilized followed by a cDNA synthesis 
reaction. Fifteen candidate miRNAs were examined for their expression levels and analyzed 
against both BMI and weight. It was found that the calculated change in quantification cycle 
from stable miRNA expression, or DCq, of miR-486-5p and miR-885-5p both individually 
showed negative associations with BMI. The DCq of miR-486-5p additionally showed a negative 
association with weight, along with the DCq of let-7i-5p and the Cq of miR-194-5p. The 
observed associations were found to be weak, but it is proposed that this is mostly due to the 
small sample size of this study. However, the data collected in this study, when analyzed using 
predictive models, was shown to have some success with a classification and regression tree 
analysis and a high level of success when utilizing a support vector machine model. This 
research demonstrates the possibility of adding environmentally impacted EVCs into current 
phenotyping panels. Recommendations for future work include the testing of additional markers 
and the use of a larger set of samples from the population. 
 
 
Keywords: forensic science, forensic biology, DNA phenotyping, BMI estimation, blood swabs, 
miRNA expression  
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Introduction 
 The use of short tandem repeats (STRs) found in the human genome for forensic analysis 
has been regarded as the gold standard in the field of forensic biology. These have proven to  
produce reliable results even with low-level and partially degraded DNA, often the case of 
forensic samples (1). While this type of analysis can be imperative in the understanding of a 
crime, the DNA profile produced may only be useful in the comparison to known profiles. When 
suspects are eliminated from contributing to the DNA profile found on evidence or when there 
are no known suspects nor databank hits, further examination may give investigators leads based 
upon phenotypic features inferred from the same biological evidence.  
 Single nucleotide polymorphisms (SNPs) are known to be useful identifiers for specific 
genes and have been used as markers to predict various phenotypic appearances (2). SNPs 
associated with phenotypes due to pigmentation have been some of the most investigated. For 
example, blue versus brown eye color has been shown to be highly predictive with about a 90% 
success rate for each using the IrisPlex multiplex assay (3,4). In addition, the newer HIrisPlex 
system combines eye color prediction with reliable hair color prediction, both independent from 
bio-geographic ancestry (5). While less reliable and much more explorative, SNPs have been 
recognized as potential biomarkers for the prediction of facial features as well, such as eyebrow 
width, eye distance. In addition, previously identified markers for sex and biogeographic 
ancestry have also been found to aid in the prediction of facial features (6). Methods outside of 
using SNPs have also been identified as predictors of phenotypes such as DNA methylation. 
certain DNA methylation sites are associated with the age of an individual and can accurately 
predict age (±6 years) 77.30% of the time in individuals under 60 years of age (7). Known age-
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informative CpGs have since been investigated as biomarkers with low-level DNA input, as the 
case with most forensic samples, showing promising results with as low as 20ng of DNA (8). 
 MicroRNAs (miRNAs), particularly extracellular miRNAs, are RNA molecules 18-24 
nucleotides long and are known to have regulatory functions with neighboring cells (9). Their 
regulatory functions and stability due to their small size have proven miRNAs to be useful in the 
determination of the age of a biological stain as well as the age of an individual (10,11).  Similar 
to age of individuals, miRNA expression levels have been shown to suggest postmortem 
intervals in incisional wounds (12). 
 Body mass index (BMI) is a measurement of body fat, and is calculated by dividing an 
individual’s weight (kg) by their height squared (m2). BMI or body weight prediction would 
provide an immense asset to the forensic community if added to a larger panel of phenotype 
markers, providing another piece of information to create a more accurate image of an individual 
solely from a biological sample. While not yet investigated for forensic purposes, there have 
been significant advances in biomedical research regarding the relationship of certain biomarkers 
and BMI due to the known correlations that BMI has with various health risks. Similar to the 
findings about age and the methylation of CpG sites (7), methylation levels at certain loci in 
blood cells have been found to be associated with BMI (13). It has been found that high BMI 
levels are also associated in changes of messenger RNA (mRNA) expression, including 
inflammatory related mRNAs in the brain (14). Similarly, certain variants in BMI-related genes 
affect the efficiency of miRNAs to bind to those genes, making them less able to block the 
production of protein (15).  
 As the understanding of miRNAs and their functions are explored, so are the 
relationships between expression levels and phenotypes. As the body mass index (BMI) of an 
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individual can be highly dependent on metabolic factors, biomarkers such as SNPs become less 
useful in the estimation of BMI from body fluid samples. miRNAs become an ideal candidate for 
predicting this category of phenotypes as the regulation of genes change alongside these 
metabolic factors.  
 Specific miRNA candidates that correlate with BMI have been identified in published 
biomedical research, demonstrating linear relationships with miRNA expression levels in plasma 
and a varying range of BMIs. In a study investigating predictors of metabolic syndrome, 
relationships were observed between two circulating plasma miRNAs and BMI, as well as 
relationships with other predictors such as waist circumference, blood pressure, and plasma 
glucose (16). A total of 19 circulating plasma miRNAs were found to have significant 
associations with BMI, with three specific miRNAs (miR-122-5p, miR-148a-3p, miR-505-3p) 
showing the most significant associations with q < 0.001 (17). In addition, some of those 
identified miRNA markers have been confirmed to correlate with BMI through previous studies 
in our research laboratory using RNA from plasma samples from individuals with known BMIs 
ranging from normal weight (BMI = 18.5-24.9) to obese (BMI ≥ 30), with the most interesting 
trends seeming to show between BMI and miRNAs miR-106a, miR-185-5p, and let-7i-5p 
(Figure 1). It is hypothesized that these same correlations between miRNA expression levels and 
BMI are to be observed in dried whole blood, commonly encountered in forensic evidence 
samples, along with various other body fluids which would allow for the addition of these 
biomarkers to a larger phenotypic panel to aid in investigative leads.  
 Furthermore, it has been previously demonstrated in our laboratory that traditional 
forensic DNA extraction methods are consistently effective in coextracting miRNA with DNA, 
although a lower miRNA yield than that observed with RNA specific extraction methods was 
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observed (18). It is therefore additionally hypothesized that using a DNA specific extraction 
method in this study would be efficiently isolate miRNA for downstream expression profile 
analysis, indicating the applicability of integrating miRNA-based techniques into forensic 
biology workflows.  
 
Methods 
Sample Selection and DNA/RNA Extraction 
 A total of 25 dried whole blood samples of known origin collected on sterile cotton 
swabs and stored at room temperature were taken from the VCU Forensic Science Department 
IRB-approved Forensic Science Biological Samples Registry (HM20002931). BMI was 
calculated and categorized according to the Centers for Disease Control and Prevention 
guidelines (19). Samples were selected so that all BMI categories were represented, ranging from 
underweight to obese, as shown in Table 1. Based on the demonstrated ability to isolate miRNA 
from DNA extracts (17), DNA was extracted from the samples using the QIAcube (Qiagen, 
Hilden, Germany) instrument using the QIAamp DNA Investigator Kit reagents and following 
the Forensic Casework sample protocol with an elution volume of 30μL. Extracts were stored at 
-20°C until use. 
Reverse Transcription of miRNA Extracts 
 Reverse transcription was performed on the Proflex PCR System (Thermo Fisher 
Scientific, Waltham, MA) using the qScriptTM miRNA Quantification System (Quanta 
Biosciences, Gaithersburg, MD). Using the reagents provided from the the qScriptTM miRNA 
Quantification System (Quanta Biosciences), the first reaction was performed by adding 2μL 
Poly(A) Tailing Buffer, 7μL of extracted DNA, and 0.6μL of Poly(A) Polymerase, followed by 
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an incubation of 37°C for 40 minutes, and then 70°C for five minutes. The cDNA synthesis 
reaction was performed by adding 9μL of microRNA cDNA Reaction Mix and 1μL of qScript 
Reverse Transcriptase to the previous reaction mix. This reaction was incubated for 20 minutes 
at 42°C followed by five minutes at 85°C. The resulting cDNA solution was stored at -20°C until 
use.  
Amplification and Detection 
 Specific qPCR primers were used for each candidate miRNA and obtained from IDT 
(Integrated DNA Technologies, Coralville, IA, USA) (Table 2). All new primers were tested 
prior to the experiment using samples consisting of DNA extract, DNase treated DNA extract, 
reverse transcribed miRNA from DNA extract, and reverse transcribed miRNA from DNase 
treated DNA extract to ensure specificity of the primer to miRNA. Only primers that showed 
similar amplification of product in the reverse transcribed DNA extract sample and product in 
the reverse transcribed DNase treated extract without amplification in either of the two non-
reverse transcribed DNA extract samples were used.  
 Each miRNA target was amplified in single wells for each sample by mixing 6.25μL 
PerfeCTa SYBR Green SuperMix (2X) (Quanta Biosciences), 0.25μL PerfeCTa microRNA 
Assay Primer (10μM) (Integrated DNA Technologies), 0.25μL PerfeCTa Universal PCR Primer 
(10μM) (qScriptTM miRNA Quantification System, Quanta Biosciences), 3.75μL nuclease-free 
water, and 2μL microRNA cDNA. The 3-step cycling protocol was as follows: 2min pre-
incubation at 95°C; 40 PCR cycles consisting of 95°C for 5sec, 60°C for 15sec, and 70°C for 
34sec; and a final extension stage comprised of 95°C for 15sec, 60°C for 1min, and 95°C for 
15sec. 
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 Raw data was analyzed within the QuantStudio TM Real-Time PCR software v1.3 
(Thermo Fisher Scientific) using a quantification cycle (Cq) threshold of 0.015. Differential 
expression or delta cycle threshold (DCq) values were calculated by subtracting the candidate 
miRNA Cq value from the let-7g Cq value, as let-7g has been shown to show stable expression 
across samples (20). All samples with an undetectable amount of miRNA expression were given 
a Cq value of 40 for analysis purposes.  
Data Analysis 
 Data was first visualized using Microsoft Excel (Microsoft Corporation, Redmond, WA) 
to show general trends between BMI, DCq, Cq, and weight. Promising markers from visual 
examination of the data were then analyzed in RStudio v4.0.2 (Integrated Development 
Environment for R, Boston, MA) (21). Linearity and homoscedasticity were confirmed for all 
sample sets using quantile-quantile plots. A simple linear regression test was performed; due to 
the preliminary nature of this work, a confidence level of 0.90 was utilized (p < 0.10 was 
considered statistically significant). To assess the predictive qualities and strength of the miRNA 
markers selected in this study, data from all markers (both raw Cq and DCq) were combined and 
used in a classification and regression tree (CART) analysis in RStudio using the rpart and 
rpart.plot packages. Additionally, a support vector machine (SVM) model (type: C-classification; 
kernel: linear; cost: 1) was analyzed using the package e1071. R code for each analysis is shown 
in Supplemental Table 1.  
 
Results and Discussion 
Sample Selection and Primer Validation 
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 Selection of samples used in this project were limited to those with recorded weight and 
height. The CDC’s guidelines for BMI calculation were used to determine if the samples 
belonged to the underweight, normal, overweight, or obese categories. Samples were then chosen 
in order to have representation among all four categories, as shown in Table 1. Due to the 
limitations of only being able to use samples with recorded weight and height and not being able 
to collect new samples due to the COVID-19 pandemic, all BMI categories could not be equally 
represented. In addition, two miRNA primers selected for this study could not be validated using 
the methods described above. These two miRNA candidates, miR-193b-3p and miR-122-5p, 
were therefore not tested or further used for this study.  
Preliminary Analysis/Visualization 
 Analysis of the raw results from amplification of the selected miRNA candidates showed 
that seven of the 15 targets had at least one sample with undetectable amounts of miRNA 
expression. While it has been demonstrated that miRNA can be coextracted using traditional 
DNA extraction methods, there is known reduction in sensitivity when comparing RNA 
extraction methods to DNA extraction methods for the purpose of extraction RNA (19). While 
this issue could be resolved using specific RNA extraction techniques, it would be at the cost of 
implementing a separate step from the already established DNA workflow for the lab analyst, 
costing time, materials, and consumption of sample. It is important to note that while random 
undetectable miRNA expression is an issue with some of the observed results of this experiment, 
observing an entire category of samples with mostly undetectable miRNA expression may 
strengthen the power of using these miRNAs to discriminate between BMI categories. 
 When amplification results were analyzed visually, there was also interest in evaluating 
the data strictly by weight as well as the initial proposal of analyzing BMI, as it is known that 
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BMI is not a perfect system of determining body fat percentage (22). Two specific miRNA 
targets, miR-486-5p and miR-885-5p, showed interesting trends when analyzed using 
scatterplots based on DCq and BMI (Figure 2). Additionally, DCq expression from miR-486-5p 
seemed to show a linear trend when compared against donor weight (Figure 3). Two final 
markers of interest were let-7i-5p and miR-194-5p, which seemed to show trends between their 
respective raw Cq values and donor weight (Figure 4). In contrast, miR-143-3p demonstrated no 
apparent trend in the data and therefore was not selected for any further statistical analysis 
(Figure 5). Once these preliminary visual identifications were made, miR-486-5p, miR-885-5p, 
miR-486-5p, let-7i-5p, and miR-194-5p were analyzed for association using RStudio. All 
selected targets were firstly analyzed using quantile-quantile plots to determine linearity and 
homoscedasticity (Figure 6).  
Association Analyses 
 When preliminarily visualizing data, a seemingly linear relationship was observed 
between DCq and BMI for both miR-486-5p and miR-885-5p (Figure 2). The results from a 
simple linear regression analysis showed that the DCq value of miR-486-5p (p = 0.0822, R2 = 
0.1256) and miR-885-5p (p = 0.0939, R2 = 0.1172) could explain 12.56% and 11.72% of the 
observed variability in BMI respectively, leading to a determination that both have a negative 
association with BMI (Figure 7A&B). Likewise, analysis of the DCq from miR-486-5p (p = 
0.036, R2 = 0.1775) showed it could explain 17.75% of the observed variability in donor weight, 
demonstrating a negative association as well (Figure 7C).  
 While the previously mentioned associations were found using DCq, let-7i-5p and miR-
194-5p seemed to show a linear relationship between the raw Cq values and donor weight 
(Figure 4). Using a simple linear regression analysis, let-7i-5p (p = 0.04977, R2 = 0.1572) and 
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miR-194-5p (p = 0.0866, R2 = 0.1223) could explain 15.72% and 12.23% of the observed 
variability in donor weight respectively, leading to a determination that both have a negative 
association with donor weight (Figure 8).  
 Markers found to be significant from the simple linear regression analyses with similar 
predictors were analyzed together using a multiple linear regression analysis. When analyzed 
together against the calculated BMI, the DCq values from miR-486-4p and miR-885-5p did not 
prove to hold any statistical significance (p = 0.1085). Additionally, the Cq values from let-7i-5p 
and miR-194-5p were analyzed together using a multiple linear regression analysis, but had no 
statistical significance as well (p = 0.1518).   
 While not found to be statistically significant, interesting trends were observed for 
several miRNA targets from the visual examination of the data by scatterplots. Interesting trends 
of note were between DCq and BMI with two observed outliers for miR-365-3p, between DCq 
and BMI with three observed outliers for miR-20a-5p, between DCq and weight for miR-145-5p, 
and between Cq and weight for miR-505-3p when excluding observed outliers from undetectable 
samples (Figure 9).  
 While it was initially proposed that the trends observed for circulating plasma miRNAs 
would continue with dried whole blood samples, starkly different trends were observed. For 
example, when using blood serum and an RNA extraction method, no meaningful trends were 
observed when DCq was plotted against BMI for either miR-486-5p or miR-885-5p (Figure 1). 
However, these two markers showed a statistically significant association between DCq and BMI 
with dried whole blood samples and using a DNA extraction method, as discussed above. 
Additionally, markers which seemed to be promising from the previous validation, such as miR-
106a or miR-99a-5p, did not show any significance or possible trends in this study. It should also 
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be noted that the previous validation using blood serum and an RNA extraction method did not 
include any underweight individuals. Even so, the visualized trends from the normal to obese 
samples did not correspond with the results presented from this study either.  
 The most obvious potential explanation for the differences observed in this study could 
be due to the shift from analyzing total miRNA from blood serum to total miRNA in whole 
blood. While individual miRNA expression profiles may be consistent when analyzing 
circulating miRNAs specifically, analyzing miRNA expression from whole blood will also 
display any intracellular miRNA expression from leukocytes and erythrocytes as well, 
potentially changing the entire expression profile (23, 24). This is especially true for this study 
and miRNAs associated with BMI, as leukocyte count can increase with higher BMI levels (25). 
In addition to leukocytes, erythrocytes also contain miRNA and miR-486-5p, a statistically 
significant marker in this study, has specifically been observed to be one of the major miRNAs 
found in erythrocytes (26). It is also a possibility that the chosen extraction method could be a 
factor in the difference in observed results. Random samples with undetectable amounts of 
amplification product were observed for some miRNA targets in this study, and therefore 
contributed as outliers, potentially skewing trends with either BMI or donor weight.  
 For the four markers found to hold statistically significant associations from the simple 
linear regression analyses, boxplots were constructed to analyze any potential differences 
observed between the reported sexes of the donors. Plots were first made to compare if any 
overall differences between sexes for both BMI and donor weight could be identified (Figure 
10). As it was already known that more female samples were used in the sample set for this study 
(19 females, six males), it was not surprising to see that females were shown to have a lower 
average weight than males, as males were more underrepresented in the underweight and normal 
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BMI categories, however distribution of BMI was similar between the two. Plots were also 
constructed to show the distribution of either DCq or Cq for each marker found to be of statistical 
significance from the simple linear regression analysis with either BMI or donor weight (Figure 
11). Although differences were observed, distributions were not different enough to be 
unexpected considering the sample size. While no notable differences were observed in regards 
to sex in these results, future studies should try to maintain equal representation of sexes within 
sample sets when available.  
 It is not too surprising that the four significant markers identified from the simple linear 
regression analyses in this study have some sort of association with weight or the calculated BMI 
as there have been published studies discussing their potential roles with weight-related factors. 
The first discussed target, miR-486-5p, has been demonstrated to be involved in the regulation of 
proliferation of human adipose-derived mesenchymal stem cells (27). While this does not 
explain the observed results from this study, knowing the roles that these miRNAs play with 
adipocytes is not surprising considering the relationship between adipocyte hyperplasia and BMI 
(28). In addition, an upregulation of miR-885-5p has been observed in individuals with fatty liver 
disease (29). The association observed in this study may potentially be partially explained by this 
association as BMI is known to be associated with fatty liver risk (30). Another significant 
marker, let-7i-5p, has been suggested to be involved in the browning process of white 
adipocytes, having a decreased expression in brite adipocytes (31). While more studies need to 
be performed to confirm, these findings seem to contradict the results observed from this study, 
since it can be inferred that individuals with lower overall weight would have increased 
browning of adipose tissue when compared to individuals with higher weight; however, the 
overexpression of let-7i-5p was observed to repress brite adipocyte function (31). Lastly, miR-
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194-5p is not very well characterized with its relationship to BMI or weight; however, it has 
been observed that there is a significant decrease in expression levels when analyzing the kidney 
tissue of diabetic mice (32). 
Predictive Models 
 Although any associations analyzed were found to be weak, a CART analysis was 
included to determine when Cq and DCq data from all markers were combined, if any useful 
determinations could be made to allow for the classification of samples into BMI groups. The 
resulting classification tree is shown in Figure 12A with the Cq data from miR-505-3p being 
recognized as the most predictive, separating samples with a Cq value ³ 35 into the normal 
weight category, with the rest of the samples categorized as overweight. As shown in Table 3A, 
eight out of the nine normal weight individuals were correctly classified (88%), while one 
individual was misclassified as overweight. Five out of seven individuals were correctly 
classified as overweight (71%), with two individuals misclassified as normal. Four of the obese 
individuals were classified as normal, two obese individuals classified as overweight, and all 
underweight individuals were classified as normal (52% correct overall). The same results were 
yielded when a CART analysis was performed using strictly raw Cq data.  
 Additionally, a CART analysis was performed using strictly DCq values for each target 
miRNA, and miR-194-5p was determined to be the most predictive separating individuals with a 
DCq of -4.6 or greater into the normal category, and all other individuals into the obese category 
(Figure 12B). As shown in Table 3B, eight normal weight individuals were correctly classified 
(88%), while one individual was classified as obese. Four out of the five obese individuals were 
correctly classified (80%), with one individual incorrectly classified as normal. Five overweight 
individuals were classified as normal, with the other two overweight individuals classified as 
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obese. One underweight individual was classified as normal, with the other four classified as 
obese (48% correct overall). The addition of sex as a predictor in all CART analyses did not 
prove to contribute to any predictions.  
 In addition to the CART analyses, a SVM model was used for classification prediction of 
individuals. The SVM was able to correctly classify each individual to its corresponding BMI 
category when blindly tested using both the raw Cq and DCq values collected from this study as 
a training set (100% correct overall) (Table 4A). While the correct classification rate for this 
model is incredibly high, it is important to emphasize the role that the small size of the dataset 
may play with these predictions. The small sample size contributes to the potential that the data 
is overfit, meaning more data will most likely render the model less accurate than observed in 
this study. Consequently, when only using raw Cq values as the training set, one individual was 
misclassified (94% correct overall) (Table 4B). A larger sample set will need to be analyzed to 
evaluate the true classification accuracy of using SVM as a model for phenotypic prediction.  
Integration into Phenotypic Panel 
 Although the association between the analyzed miRNA expression patterns and 
BMI/weight were not considerably strong, there was some found success observed in the 
categorization of samples into BMI categories using a CART analysis and SVM model. These 
observed associations, along with the success in using this small sample set with predictive 
models, provides confidence that further research may discover that BMI or weight prediction in 
a phenotypic panel is very much possible. Further research with an expanded sample set 
including all BMI categories and a variance in weight of individuals is needed to confirm the 
associations and success with this project.  
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 Along with an expanded sample set, an increase in miRNA targets is suggested as well, 
including miR-223, miR-125b, miR-221, miR-199b-3p, miR-199-5p, miR-100, miR-10a, miR-
34a, miR-199a-5p, miR-1229, miR-210, miR-99b, miR-92a, miR-142-5p, miR-130b, miR-484, 
miR-133b, and miR-236. It has been observed that circulating miR-223 expression in blood 
serum is lower in individuals with higher BMI than in normal-weight individuals, and 
additionally has been shown to increase when the BMI of individuals is lowered due to lifestyle 
changes (33). Additionally, miR-133b and miR-236 should be investigated further as potential 
biomarkers to help identify underweight individuals. These two miRNAs have been observed to 
offer a potential connection between their expression values, nutrition, and age-related skeletal 
muscle decline when analyzing expression values in plasma (34). While a classification of 
underweight with respect to BMI does not strictly mean an individual is malnourished, it is 
proposed that these two miRNAs may potentially show an association between underweight 
individuals and observed expression. Lastly, the remaining miRNAs addressed above have been 
observed to have significant associations with BMI when analyzing subcutaneous adipose tissue 
(35). Since two of the associated markers in this study have been demonstrated to be expressed 
in and have functions with adipocytes, it is hypothesized that these listed markers may also have 
detectable levels of expression in whole blood samples. Additions to the four miRNAs observed 
in this study would be helpful in strengthening the value of BMI/weight predictive models when 
integrating into a phenotypic panel. 
Expansion to Other Forensically Relevant Body Fluids 
 If continued associations were to be observed using an expanded sample set with dried 
whole blood, it is suggested that this project should be expanded to investigate associations with 
other forensically relevant body fluids, such as saliva. Since inflammatory response proteins can 
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be detected in saliva samples (36), it is proposed that saliva would potentially uphold many 
associations found between miRNA and BMI/weight observed in whole blood. It has been 
documented that adipose tissue is responsible for an inflammatory response to obesity (37). 
Since two of the miRNAs discussed in this study are known to be related to adipocytes and 
therefore potentially inflammation, inflammatory-related miRNAs (triggered by a high BMI) 
may potentially be able to be detected in saliva samples at similar expression patterns as shown 
in whole blood. 
 
Conclusion 
 With increasing amounts of biological samples being submitted to forensic laboratories, 
the issue of producing DNA profiles without any useful known profile for comparison is also 
increasing. Predictive phenotyping is currently being introduced in such cases where a suspect 
may be unknown; however, this method for investigative leads currently only provides specific 
information from markers that are stable in the genome from birth. If associations between 
miRNA expression levels and metabolic or environmentally impacted phenotypes could be 
identified, characteristics such as BMI or weight could then be predicted just as hair, eye, or skin 
color. The goal of this project was to identify miRNA candidates that correlate with BMI using 
dried whole blood samples and methodology typical for a forensic laboratory to be used in 
further research for incorporation of these markers into a larger phenotyping panel for 
investigative purposes.  
 Previous work had identified multiple circulating plasma miRNAs shown to have strong 
associations with BMI (17), which were the markers selected for investigation in this study. In 
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contrast to the previous study, a DNA extraction method was used to show the ability to integrate 
miRNA analysis easily into the current typical forensic case workflow.  
 It was initially proposed that similar trends would be observed in this study as compared 
to those from a previous validation of the same markers using blood serum and an RNA 
extraction technique. The results of this study prove that while the same trends are not observed, 
miRNA targets analyzed still demonstrated statistically significant associations with either BMI 
or weight. Two candidate miRNAs (miR-486-5 and miR-885-5p) have an association with BMI 
and three candidate miRNAs (miR-486-5p, let-7i-5p, and miR-194-5p) have an association with 
weight. While these associations are not strong, these findings, put into perspective with the 
small sample size used, are promising for further research.  
 Through the use of a CART analysis as a means of a predictive model, eight out of nine 
normal weight individuals and five out of seven overweight individuals are correctly classified, 
with a total of 13 out of 25 total samples correctly classified using the combined Cq and DCq 
values. Using only raw Cq values, eight out of nine normal weight individuals and four out of 
five obese individuals are correctly classified, with a total of 12 out of 25 total samples correctly 
classified. All samples are correctly predicted into their respective BMI categories using an SVM 
model and combined Cq and DCq data. However, the possibility of the data being overfit due to 
the small sample size is very likely. This demonstrates the need for the addition of a larger 
sample size and the addition of more miRNA markers to further the ability to confidently 
separate between BMI groups.  
 In conclusion, the findings of this study prove that associations between miRNA 
expression due to a response to metabolic factors, such as BMI or weight, can be detected in 
complex forensic sample types such as whole dried blood. It is proposed that with a larger 
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sample set, stronger associations may be identified and, therefore, be used for the optimization of 
predictive models for either BMI or weight. In order to further this research, a larger sample size 
should be used along with the testing of more target miRNAs. If continued associations were to 
be found, predictive modeling applications, such as the CART analyses and SVM model 
predictions demonstrated in this study, could be optimized. If accurate, miRNA markers could be 
used in conjunction together for BMI or weight prediction and added to a larger forensic DNA 
phenotyping panel to be used for investigative purposes.  
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Figure 1. miRNA expression from preliminary study using blood serum and an RNA isolation 
method and samples with known BMI ranging from normal (BMI = 18.5-24.9), overweight 





Table 1. Selected samples 
 
Sample Sex Race Weight (lbs) Height (in) BMI 
7046 Male Caucasian 115 69 17.0 
5117 Female Asian 106 65 17.6 
8018 Female Asian 105 64 18.0 
1222 Female African American 123 69 18.2 
8021 Female Caucasian 130 65 21.6 
8026 Female African American 119 62 21.8 
1087 Female Asian 125 63 22.1 
8004 Female Hispanic 135 65 22.5 
5137 Female Caucasian 145 67 22.7 
8016 Female Caucasian 150 68 22.8 
8020 Female Caucasian 146 66 23.6 
1213 Male Asian 160 69 23.6 
1088 Female African American 140 64 24.0 
8008 Male  Caucasian 175 68 26.6 
7042 Male African American 175 66 28.2 
1090 Female Caucasian 162 63.5 28.2 
1081 Female Caucasian 170 65 28.3 
8031 Female Asian 150 61 28.3 
7505 Male Asian 198 70 28.4 
1089 Female Hispanic 180 66 29.0 
7504 Female Asian 180 65 30.0 
7507 Female African American 180 65 30.0 
1220 Male Caucasian/Pacific Islander 225 71 31.4 
8015 Female Chinese 125 52 32.5 
1085 Female Caucasian 210 66 33.9 
Blood samples selected from the IRB-approved registry and used for testing. BMI is colored 
based on category with green representing underweight individuals (BMI < 18.5) (4), yellow 
representing normal weight individuals (BMI = 18.5-24.9) (9), orange representing overweight 
individuals (BMI = 25-29.9) (7), and red representing obese individuals (BMI ≥ 30) (5). 
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Table 2. Candidate miRNAs 
 
miRNA ID Accession # Human miRNA Sequence Primer Sequence 
hsa-miR-20a-5p* MIMAT0000075 UAAAGUGCUUAUAGUGCAGGUAG 
CGCTAAAGTGCTT
ATAGTGCAGGT 
hsa-miR-93-5p* MIMAT0000093 CAAAGUGCUGUUCGUGCAGGUAG 
AAAGTGCTGTTCG
TGCAGGT 
hsa-miR-99a-5p** MIMAT0000097 AACCCGUAGAUCCGAUCUUGUG 
CGCCAACCCGTAG
ATCC 
hsa-miR-106a-5p MIMAT0000103 AAAAGUGCUUACAGUGCAGGUAG 
CGCCAAAAGTGCT
TACAGTGC 
hsa-miR-143-3p* MIMAT0000435 UGAGAUGAAGCACUGUAGCUC 
TGAGATGAAGCAC
TGTAGCTCAAA 
hsa-miR-145-5p MIMAT0000437 GUCCAGUUUUCCCAGGAAUCCCU 
CAGTTTTCCCAGG
AATCCCTAA 
hsa-miR-148a-3p* MIMAT0000243 UCAGUGCACUACAGAACUUUGU 
CGCTCAGTGCACT
ACAGAACTTT 
hsa-miR-185-5p MIMAT0000455 UGGAGAGAAAGGCAGUUCCUGA 
TGGAGAGAAAGGC
AGTTCCTG 
hsa-miR-194-5p MIMAT0000460 UGUAACAGCAACUCCAUGUGGA 
ACAGCAACTCCAT
GTGGAAAA 
hsa-miR-215-5p MIMAT0000272 AUGACCUAUGAAUUGACAGAC 
CGCATGACCTATG
AATTGACAGAC 
hsa-miR-365a-3p* MIMAT0000710 UAAUGCCCCUAAAAAUCCUUAU 
CGTAATGCCCCTA
AAAATCCTT 
hsa-miR-486-5p MIMAT0002177 UCCUGUACUGAGCUGCCCCGAG 
GAGCTGCCCCGAG
AAAAA 
hsa-miR-505-3p MIMAT0002876 CGUCAACACUUGCUGGUUUCCU 
CGTCAACACTTGC
TGGTTTCC 
hsa-miR-885-5p MIMAT0004947 UCCAUUACACUACCCUGCCUCU 
TCCATTACACTAC
CCTGCCTCT 
hsa-let-7i-5p MIMAT0000415 UGAGGUAGUAGUUUGUGCUGUU 
CGTTCTGAGGTAG
TAGTTTGTGCT 
*excluded from combined (Cq and DCq) support-vector machine analysis due to missingness 
from some samples 







Figure 2. Observed relationships between DCq and BMI 
Calculated DCq using let-7g as the normalizer plotted against the known donor BMI for (A) 
miR-486-5p and (B) miR-885-5p. Samples are colored according to BMI classification with 
underweight (green), normal (yellow), overweight (orange), and obese (red). Trendline added to 





Figure 3. Observed relationship between DCq and weight 
Calculated DCq using let-7g as the normalizer plotted against the known donor weight for miR-
486-5p. Trendline added to show potential negative association between miRNA expression and 








Figure 4. Observed relationship between Cq and weight 
Observed Cq plotted against the known donor weight for (A) let-7i-5p and (B) miR-194-5p. 





Figure 5. Example miRNA of no interest 
Example of miRNA marker (miR-143-3p) showing no trend of interest when calculated DCq was 
plotted against the known donor BMI. Samples are colored according to BMI classification with 
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Figure 6. Q-Q plots for association analyses 
Quantile-quantile (Q-Q) plots showing linearity and homoscedasticity for (A) BMI and (B) DCq 
observations from miR-486-5p dataset, (C) BMI and (D) DCq from the miR-885-5p dataset, (E) 
donor weight from the miR-486-5p dataset, (F) donor weight and (G) Cq from the let-7i-5p 
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Figure 7. Q-Q plots of residuals for associations with DCq 
Quantile-quantile (Q-Q) plot of residuals from simple linear regression analysis between (A) 
calculated DCq values and BMI for miR-486-5p, (B) miR-885-5p. Q-Q plot of residuals between 








Figure 8. Q-Q plot of residuals for associations with Cq 
Quantile-quantile plot of residuals from simple linear regression analysis between observed Cq 































Figure 9. Observations from preliminary study 
Trends observed in preliminary visualization of data found to not be statistically significant for 
miR-365-3p, miR-20a-5p, miR-145-5p, and miR-505-3p. Samples in plotted against BMI are 
colored according to BMI classification with underweight (green), normal (yellow), overweight 










Figure 10. Observed differences between sexes for BMI and weight 
Boxplots showing observed differences between (A) reported donor sex and BMI, as well as (B) 
donor weight. Differences in distribution of female vs male donor weight due to more females 
represented in sample set. 19 females and six males were included in the sample set. 
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Figure 11. Observed differences between sexes for analyzed miRNAs 
Boxplots showing observed distribution of either DCq or Cq of miRNA markers with statistically 
significant association to either BMI or donor weight with reported sex of donor. No differences 
identified between sexes were noted as unexpected for any miRNA markers.19 females and six 










Figure 12. Graphical representation of CART predictions 
Visualization of CART analyses using both raw Cq and DCq from all markers (A), as well as just 
DCq data (B).   
  
 41 
Table 3. BMI predictions from CART analyses 
 
A. 
Actual Prediction Underweight Normal Overweight Obese 
Underweight 0 4 0 0 
Normal 0 8 1 0 
Overweight 0 2 5 0 
Obese 0 4 1 0 
 
B. 
Actual Prediction Underweight Normal Overweight Obese 
Underweight 0 1 0 3 
Normal 0 8 0 1 
Overweight 0 5 0 2 
Obese 0 1 0 4 
 
Categorical BMI prediction of samples compared to known BMI categorization using CART 
analysis for (A)  all data (52% correct) and (B) just DCq data (48% correct).  
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Table 4. BMI predictions from SVM analyses 
 
A. 
Actual Prediction Underweight Normal Overweight Obese 
Underweight 4 0 0 0 
Normal 0 9 0 0 
Overweight 0 0 7 0 
Obese 0 0 0 5 
 
B. 
Actual Prediction Underweight Normal Overweight Obese 
Underweight 4 0 0 0 
Normal 0 6 0 0 
Overweight 1 0 3 0 
Obese 0 0 0 4 
 
Categorical BMI prediction using the support vector machine model using (A) combined Cq and 
DCq data (100% correct) and (B) just raw Cq data (94% correct). SVM analysis using combined 
data had 22 support vectors and the SVM analysis had 18 support vectors. Due to sample 
missingness, miRNA markers with any missing values were eliminated from the combined 
analysis. Markers used for the combined analysis were: miR-106a-5p, miR-145-5p, miR-185-5p, 
miR-194-5p, miR-215-5p, miR-486-5p, miR-505-3p, miR-885-5p, let-7i-5p. All markers were 
used for analysis consisting only of Cq values, which contributed to samples being excluded and 




Supplemental Table 1. List of R code used for each analysis in RStudio for this study 
 
Function R Code 
Quantile-Quantile Plot qqPlot() 
Simple/Multiple Linear Regression lm() 
Classification and Regression Tree rpart() rpart.plot() 
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